Insider Transactions Reported by 15 Insiders of TFF Pharmaceuticals, Inc.

Location
Austin, TX

There are no Buy or Sell transactions made by insiders since 07 Jan 2025

TFF Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Carlson Capital, L.P. 10%+ Owner $4,198,493 15 Aug 2023
Malcolm Fairbairn Director $519,876 19 May 2021
Harlan F. Weisman President and CEO, Director $347,373 03 Jul 2024
Zamaneh Mikhak Chief Medical Officer $61,005 03 Jul 2024
ROBERT S. MILLS Director $24,989 03 Jul 2024
KIRK ALLEN COLEMAN Chief Financial Officer $22,109 03 Jul 2024
STEPHEN ROCAMBOLI Director $17,165 03 Jul 2024
Glenn R. Mattes President and CEO, Director $16,839 16 May 2022
Brandi Roberts Director $11,159 03 Jul 2024
Catherine C. Lee Director $2,013 03 Jul 2024
THOMAS B. KING Director $1,838 03 Jul 2024
Michael Patane Director $1,393 18 Apr 2024
RANDY H. THURMAN Director 29 Sep 2022
Aaron G.L. Fletcher Director 29 Dec 2022
CHRISTOPHER CANO Chief Operating Officer 22 Sep 2021

Recent Insider Transactions by Companies or Individuals for TFF Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.